INDP
Indaptus Therapeutics, Inc.Company with tickers: INDP
CIK
1857044
CUSIP
45339J204
Shares Outstanding
113,242,324
13F Activity (30d)
2 filings
2 filers
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Walt A. Linscott, Esq. | Chief Operating Officer | Resigned | 2026-06-05 |